Retrospective Study Shows That Serum Levels of Chemokine CXCL10 and Cytokine GDF15 Support a Diagnosis of Sporadic Inclusion Body Myositis and Immune-Mediated Necrotizing Myopathy

The implementation of novel blood-based biomarkers is desired to reduce the diagnostic delay and burden for myositis patients. In this retrospective study, the potential of C-X-C motif chemokine ligand 10 (CXCL10) and growth differentiation factor 15 (GDF15) was explored in an established patient co...

Descripción completa

Detalles Bibliográficos
Autores principales: De Paepe, Boel, Bracke, Ken R., De Bleecker, Jan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605230/
https://www.ncbi.nlm.nih.gov/pubmed/37891738
http://dx.doi.org/10.3390/brainsci13101369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605230/
https://www.ncbi.nlm.nih.gov/pubmed/37891738
http://dx.doi.org/10.3390/brainsci13101369

Ejemplares similares